Daily high-dose ICS linked to adverse heart and lung events: study
GP asthma expert Dr Kerry Hancock says the findings underscore the importance of regular review.
Daily high-dose inhaled corticosteroids are associated with a fourfold increased risk of pneumonia and major adverse cardiac events in adults with asthma, UK researchers say.
Use of daily low-dose inhaled corticosteroids (ICS) — ≤200µg of beclomethasone equivalents — were not associated with any adverse outcomes up to a year later.
